MarkWide Research

Sale!

Respiratory Devices Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2022-2030

Published Date: July, 2022
No of Pages: 184
Delivery Format: PDF + Excel

$2,950.00

Innovation in manufacturing respiratory devices has resulted from the rising incidence of respiratory diseases. Patients with asthma and chronic obstructive lung diseases (COPD) have sought greater drug delivery precision. This has resulted in a rise in the adoption of respiratory devices. Governments have favourable reimbursement policies encouraging the manufacturing and sale of respiratory devices. MWR provides insights into key factors that drive demand for respiratory devices. This report provides information about the global sales of Respiratory Devices in 20 high-growth countries and analyzes the impact COVID-19 had on the medical devices industry in general and respiratory devices in particular.How do Combination Therapies Impact Respiratory Device Sales?

Combination therapies have been gaining popularity for treating COPD and asthma. Patients prefer combination therapies due to their increased efficacy, reliability and favourable reimbursement policies. Manufacturers of respiratory devices see a rise in demand for combination therapies, such as triple combination therapy.

Combination therapies can be a reliable treatment option for patients suffering from complex respiratory conditions. These therapies are also encouraged by favourable reimbursement schemes.

How will the adoption of portable respiratory devices aid growth?

Technology is important in improving the quality of inhalers and other nebulizers. It also makes it easier to use these devices. This would increase patient compliance. These devices are popular because they are lightweight, portable, and small enough to be carried easily. Patients with chronic respiratory conditions require continuous oxygen supply. The best portable oxygen concentrator is the one that offers many other advantages. Portable oxygen concentrators could be the next oxygen delivery device for toddlers.

The combination of cell phones with respiratory devices like spirometers, pulse oximeters, and pulse oximeters allows doctors to access telemedicine and data quickly. Demand for spirometers is expected to rise in the top regions due to government initiatives and the increasing chronic disease prevalence.

Many of the top Respiratory Devices Market players plan to launch portable devices. For instance, on April 01, 2019, InnAccel launched SAANS, which has been claimed to be the world’s first infrastructure-independent, neonatal, portable (continuous positive airway pressure) CPAP system. Aptar Pharma recently introduced PureHale, a portable, ready-to-use delivery system for upper respiratory care.

What are the effects of regulations on sales of respiratory devices?

According to the World Health Organization, COPD will be the world’s third leading cause of death by 2025. There are huge growth opportunities due to the rising incidence of respiratory diseases and increasing demand for treatment. The Respiratory Devices Market will see remarkable growth due to the introduction of favourable reimbursement policies.

Profitable growth prospects will be created by improvements in the government’s healthcare system and a growing focus on advanced treatment that is more accessible. The Affordable Care Act, for example, is being implemented to allow nearly 40 million Americans access healthcare services.

Similar services are provided in England. Every country’s citizen has access to preventive medicine, primary care, and hospital services through the National Health Service (NHS). In 2018, radical NHS changes were made to allow social workers to create care plans for patients. These care plans will increasingly be available outside of hospitals. These changes, which aim to make healthcare more accessible, will create a favourable environment for selling respiratory devices.

The universal healthcare system of Japan is also known for its low-cost healthcare policies. According to OCED, Japan’s healthcare system focuses on quality and cost control. The forecast period will see steady sales growth due to favourable regulatory policies.

There are many opportunities for COPD treatment.

MWR predicts that the COPD treatment will see a higher demand for respiratory devices. The COPD segment will grow rapidly over the next year, even though the COPD indication will remain the most popular. The market for respiratory devices will grow due to the increasing prevalence of COPD and the increase in healthcare spending around the globe.

The Global Burden of Disease Study report by WHO states that in 2016, approximately 251 million cases of COPD were diagnosed worldwide. The demand for nebulizers that treat COPD will rise in the coming years as the disease’s incidence is forecast to increase.

What is the potential for Respiratory Devices sales in the U.S?

MWR projects that the U.S. will continue to be a major Respiratory Devices Market for the forecast period. The region’s high healthcare spending is one of the main factors that support expansion. According to preliminary CMS forecasts from the Office of the Actuary (CMS), the U.S.’s total healthcare spending is expected to rise by 5.4% between 2019-2028, surpassing the country’s GDP by 4.3%.

The U.S. is still one of the most important markets for medical equipment worldwide, making it an attractive market for manufacturers of respiratory devices. Select USA forecasts that the U.S. medical device market will account for 40% of the global market by 2023. It is expected to reach 203 Bn US$ by 2023. According to the Centers for Medicare & Medicaid Services (CMS), the retail spending for durable medical equipment was 54.4 billion US$ in 2017. This is a sign of the incredible growth potential it will provide respiratory device companies.

The combination of favourable healthcare policies and high per capita healthcare spending has created an environment encouraging the adoption of respiratory devices in America. Leading players like Medtronic plc. and ResMed Inc. are helping to drive growth in the U.S. Their strategies include product launches and expansion plans, which will continue to aid in overall U.S. expansion.

U.K. Medical Device Sales Need Revival

Hospitals and other healthcare facilities across the U.K. are expected to increase their use of respiratory devices. The demand for respiratory devices will rise due to the efforts of various government agencies, such as the European Academy of Allergy & Clinical Immunology, which aims to raise awareness about COPD and other respiratory conditions such as asthma. FMI Europe is currently the second-leading market for respiratory devices, and this position is expected to continue throughout the period.

Research by the University of Edinburgh suggests that COPD treatment costs in England will exceed 2.5bn euros by 2030, according to the University of Edinburgh. This indicates that the U.K. can potentially expand its health care spending for respiratory conditions. According to the Economic Co-operation and Development Organization of the U.K., in 2017, the country spent approximately 2,989 euros per person on health. Sales prospects will improve as the U.K.’s healthcare spending is expected to rise significantly.

Why innovation is key to success in the German Medical Device Market

According to the Federal Statistical Office, Germany’s healthcare spending increased by 4% between 2017 and 2018. Germany spent 11.7% of its GDP on healthcare in 2018. Furthermore, healthcare spending is expected to rise to 407.4 trillion Euros by 2019, which presents a lucrative market for expanding and maintaining respiratory devices.

Companies such as Drgerwerk AG & Co. KGaA also support Germany’s expansion. This company provides affordable, effective technology to make Seattle PAP, a patent-pending innovation that treats respiratory distress symptoms in children and babies. The company has also been investing heavily in expansion. These companies have adopted growth strategies that will aid in Germany’s expansion.

All citizens have been required to purchase health insurance since 2009. The NCBI estimates that 70 million people are covered by statutory insurance or 85% of the country’s population. Substitute, private health insurance covers 11% of Germany’s population. Attractive growth opportunities are offered by the regulatory environment and favourable reimbursement policies.

Sales in France Closely Tied to Healthcare Spending

According to the National Center for Biotechnology Information, 530 Euros annually is paid for by COPD patients. This amount involves significant use of healthcare resources. Another survey conducted by NCBI found that COPD prevalence was between 1.0% and 11.1% in French adults. The rising demand for effective treatments results from France’s high prevalence of respiratory diseases. In France, the sales of respiratory devices are expected to rise.

The World Bank estimates that France’s healthcare spending is close to 11.25% of its GDP for 2018. While this represents a decline in healthcare spending in France than to 2017, the healthcare system is still strong. Combined with positive government initiatives, the rise in cases of respiratory disease will ensure that France’s demand for respiratory devices is high.

Competitive Landscape

To expand their product portfolio, leading players are focusing on strategic acquisitions. Masimo Corporation, for example, has purchased TNI medical A.G. (“TNI”) to provide innovative pulmonary treatment in 2020. Resmed Inc. also acquired H.B. Healthcare (HBH) and Propeller Health in 2019. This acquisition will provide connected health solutions to people with COPD and other respiratory conditions such as asthma.

To meet the needs of the growing patient population, companies in the respiratory device market are looking for strategic partnerships. Medtronic plc, for example, entered into a partnership in June 2020 with Foxconn Industrial Internet to start manufacturing Medtronics Puritan Bennett 5560 (PB560) ventilators in the United States.

Smiths Medical also signed a partnership agreement with Medline Industries to distribute the Portex acapella vibratory PEP therapy device. This will help focus on non-acute care channels and home care in 2019.

Players are focusing on innovation and USFDA approval. Key players aim to gain a competitive edge and expand their global reach as they await approvals from regulatory authorities. The USFDA approved Masimo Corporation in 2019 for Neonatal RD SETPulse Oximetry Sensors. It has improved accuracy Specifications and O3Regional Oximetry for infants and neonates. Radius PPG is the first tetherless SETpulse oximetry solution. In 2020, the USFDA approved Masimo’s Rad-G Pulse Oximeter to treat respiratory conditions.

Most companies are focusing their efforts on product launches that combine advanced technology with new ventilation solutions to provide respiratory support for infants, children, and adults. ResMed Inc., for example, launched an automated ResMed ReSupply solution in 2019 to improve long-term therapy compliance and patient satisfaction with sleep apnea.

Respiratory Devices Market Report Scope and Segmentation

ATTRIBUTESDETAILS
ESTIMATED YEAR2022
BASE YEAR2021
FORECAST YEAR2030
HISTORICAL YEAR2017-2021
UNITValue (USD Million/Billion)
BY REGIONNorth America, Europe, Asia Pacific, Latin America, Middle East and Africa

The following companies dominate the Respiratory Devices Market:

  • Massimo Corporation
  • Teleflex Incorporated
  • Fisher & Paykel Healthcare Limited
  • ResMed Inc.
  • Hamilton Medical AG
  • Medtronic plc.
  • Koninklijke Philips N.V.
  • Smiths Medical
  • General Electric Healthcare Limited
  • Drgerwerk AG & Co. KGaA
  • Inogen Inc.

Segmentation:

Product

  • Respiratory Consumables
    • Respiratory Mask
    • Nasal Cannulas
    • Oxygen Tubing Sets
    • Breathing Filters
  • Nebulizers
    • Compressed Jet Nebulizers
    • Ultrasonic Nebulizers
  • Oxygen Concentrators
    • Home Oxygen Concentrators
    • Portable Oxygen
    • Concentrators`
  • Positive Airway Pressure (PAP) Devices
  • Polysomnography Devices
    • Ambulatory PSG Devices
    • Clinical PSG Devices
  • Pulse Oximeters
  • Mechanical Ventilators
  • Spirometers

End Users

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Long Term Care Centers
  • Others

Scope of the Report

AttributeMore Details
Market for Respiratory Devices Forecast Period2021-2031
Historical data on Respiratory Devices Market Available2016-2020
Market Analysis of Respiratory DevicesUSD Million for volume and units for value
Key Regions IncludedNorth America, Latin America, Europe, East Asia, South Asia, Oceania Middle East & Africa
Market for Respiratory Devices Key CountriesUSA, Canada, Germany. U.K. France, Italy. Spain, Poland. Russia, China. South Korea. India. Thailand. Malaysia. Vietnam. Indonesia. Australia. New Zealand. GCC Countries. Turkey. Northern Africa. South Africa.
The Respiratory Devices Market Key SegmentsProduct Type, End User, and Region
Key Companies Profiled
  • Massimo Corporation
  • Teleflex Incorporated
  • Fisher & Paykel Healthcare Limited
  • ResMed Inc.
  • Hamilton Medical AG
  • Medtronic plc.
  • Koninklijke Philips N.V.
  • Smiths Medical
  • General Electric Healthcare Limited
  • Drgerwerk AG & Co. KGaA
  • Inogen Inc.
  • Other
Report coverageMarket Forecast, brand share analysis and competition intelligence, DROT analyses, Market Dynamics & Challenges, Strategic Growth Initiative

 

Region

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • Italy
    • France
    • UK
    • Spain
    • Poland
    • Russia
    • The Netherlands
    • Norway
    • Czech Republic
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Indonesia
    • Malaysia
    • Thailand
    • Singapore
    • Australia & New Zealand
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • The Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Northern Africa
    • Rest of MEA

 

Table of Contents

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting The Market

3.2. Product Development Trends

4. Market Background

4.1. Macro-Economic Factors

4.1.1. Global GDP Growth Outlook

4.1.2. Global Healthcare Expenditure Outlook

4.1.3. Growth of Healthcare Sector in Emerging Nations

4.2. Forecast Factors – Relevance & Impact

4.2.1. Global Increase in Healthcare Expenditure

4.2.2. Corporate Investments are Helping Advance R&D

4.2.3. Changing Regulatory Dynamics

4.2.4. Cost Impact

4.2.5. Regulatory Scenario

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunity Analysis

5. Key Success Factors

5.1. Product Adoption / Usage Analysis

5.2. Product USPs/ Features

5.3. Production Analysis by Region

5.4. Trade Analysis

5.5. Regulatory Scenario

5.6. Strategic Promotional Strategies by Manufacturer

6. COVID19 Crisis Impact Analysis

6.1. COVID19 Crisis Impact Analysis

6.1.1. Current COVID19 Statistics and Probable Future Impact

6.1.2. Current GDP Projection and Probable Impact

6.1.3. Current Economic Projection as compared to 2008 Economic analysis

6.1.4. COVID19 and Impact Analysis

6.2. Respiratory Devices Market Revenue Impact Analysis

6.2.1. Historical (pre-COVID), Current (during-COVID), Future (post-COVID)

6.2.1.1. By Product

6.2.1.2. By End User

6.2.1.3. By Region

6.2.2. 2020 Market Scenario

6.2.3. Quarter by Quarter Forecast

6.2.4. Projected Recovery Year

6.3. Impact on Trends Analysis

6.4. Recovery Scenario – Short term, Midterm and Long Term Impact

7. Global Respiratory Devices Market Demand (in Value or Size in US$ Mn) Analysis 2016-2020 and Forecast, 2021–2031

7.1. Historical Market Value (US$ Mn) Analysis, 2016-2020

7.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031

7.2.1. Y-o-Y Growth Trend Analysis

7.2.2. Absolute $ Opportunity Analysis

8. Global Respiratory Devices Market Analysis 2016-2020 and Forecast 2021-2031, By Product Type

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2016 – 2020

8.3. Current and Future Market Size (US$ Mn) Analysis  By Product Type, 2016 – 2020

8.3.1. Respiratory Consumables

8.3.1.1. Respiratory Mask

8.3.1.2. Nasal Cannulas

8.3.1.3. Oxygen Tubing Sets

8.3.1.4. Breathing Filters

8.3.2. Nebulizers

8.3.2.1. Compressed Jet Nebulizers

8.3.2.2. Ultrasonic Nebulizers

8.3.3. Oxygen Concentrators

8.3.3.1. Home Oxygen Concentrators

8.3.3.2. Portable Oxygen

8.3.3.3. Concentrators`

8.3.4. Positive Airway Pressure (PAP) Devices

8.3.5. Polysomnography Devices

8.3.5.1. Ambulatory PSG Devices

8.3.5.2. Clinical PSG Devices

8.3.6. Pulse Oximeters

8.3.7. Mechanical Ventilators

8.3.7.1. Spirometers

8.4. Market Attractiveness Analysis By Product Type

9. Global Respiratory Devices Market Analysis 2016-2020 and Forecast 2021-2031, By End User

9.1. Introduction / Key Findings

9.2. Historical Market Size (US$ Mn) Analysis By End User, 2016 – 2020

9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2021 – 2031

9.3.1. Hospitals

9.3.2. Ambulatory Surgical Centers

9.3.3. Clinics

9.3.4. Long Term Care Centers

9.3.5. Others

9.4. Market Attractiveness Analysis By End User

10. Global Respiratory Devices Market Analysis 2016-2020 and Forecast 2021-2031, by Region

10.1. Introduction

10.2. Historical Market Size (US$ Mn) Analysis By Region, 2016 – 2020

10.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2021 – 2031

10.3.1. North America

10.3.2. Latin America

10.3.3. Europe

10.3.4. East Asia

10.3.5. South Asia

10.3.6. Oceania

10.3.7. Middle East and Africa (MEA)

10.4. Market Attractiveness Analysis By Region

11. North America Respiratory Devices Market Analysis 2016-2020 and Forecast 2021-2031

11.1. Introduction

11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016 – 2020

11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 – 2031

11.3.1. By Country

11.3.1.1. U.S.

11.3.1.2. Canada

11.3.2. By Product Type

11.3.3. By End User

11.4. Market Attractiveness Analysis

11.5. Key Market Participants – Intensity Mapping

11.6. Drivers and Restraints – Impact Analysis

12. Latin America Respiratory Devices Market Analysis 2016-2020 and Forecast 2021-2031

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016 – 2020

12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 – 2031

12.3.1. By Country

12.3.1.1. Brazil

12.3.1.2. Mexico

12.3.1.3. Argentina

12.3.1.4. Rest of Latin America

12.3.2. By Product Type

12.3.3. By End User

12.4. Market Attractiveness Analysis

12.5. Key Market Participants – Intensity Mapping

12.6. Drivers and Restraints – Impact Analysis

13. Europe Respiratory Devices Market Analysis 2016-2020 and Forecast 2021-2031

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016 – 2020

13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 – 2031

13.3.1. By Country

13.3.1.1. Germany

13.3.1.2. Italy

13.3.1.3. France

13.3.1.4. U.K.

13.3.1.5. Spain

13.3.1.6. BENELUX

13.3.1.7. Russia

13.3.1.8. Rest of Europe

13.3.2. By Product Type

13.3.3. By End User

13.4. Market Attractiveness Analysis

13.5. Key Market Participants – Intensity Mapping

13.6. Drivers and Restraints – Impact Analysis

14. South Asia Respiratory Devices Market Analysis 2016-2020 and Forecast 2021-2031

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016 – 2020

14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 – 2031

14.3.1. By Country

14.3.1.1. India

14.3.1.2. Thailand

14.3.1.3. Indonesia

14.3.1.4. Malaysia

14.3.1.5. Rest of South Asia

14.3.2. By Product Type

14.3.3. By End User

14.4. Market Attractiveness Analysis

14.5. Key Market Participants – Intensity Mapping

14.6. Drivers and Restraints – Impact Analysis

15. East Asia Respiratory Devices Market Analysis 2016-2020 and Forecast 2021-2031

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016 – 2020

15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 – 2031

15.3.1. By Country

15.3.1.1. China

15.3.1.2. Japan

15.3.1.3. South Korea

15.3.2. By Product Type

15.3.3. By End User

15.4. Market Attractiveness Analysis

15.5. Key Market Participants – Intensity Mapping

15.6. Drivers and Restraints – Impact Analysis

16. Oceania Respiratory Devices Market Analysis 2016-2020 and Forecast 2021-2031

16.1. Introduction

16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016 – 2020

16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 – 2031

16.3.1. By Country

16.3.1.1. Australia

16.3.1.2. New Zealand

16.3.2. By Product Type

16.3.3. By Application

16.3.4. By Injector

16.3.5. By End User

16.4. Market Attractiveness Analysis

16.5. Key Market Participants – Intensity Mapping

16.6. Drivers and Restraints – Impact Analysis

17. Middle East and Africa Respiratory Devices Market Analysis 2016-2020 and Forecast 2021-2031

17.1. Introduction

17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016 – 2020

17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 – 2031

17.3.1. By Country

17.3.1.1. GCC Countries

17.3.1.2. South Africa

17.3.1.3. Rest of Middle East and Africa

17.3.2. By Product Type

17.3.3. By End User

17.4. Market Attractiveness Analysis

17.5. Key Market Participants – Intensity Mapping

17.6. Drivers and Restraints – Impact Analysis

18. Key and Emerging Countries Respiratory Devices Market Analysis 2016-2020 and Forecast 2021-2031

18.1. Introduction

18.1.1. Market Value Proportion Analysis, By Key Countries

18.1.2. Global Vs. Country Growth Comparison

18.2. U.S. Respiratory Devices Market Analysis

18.2.1. By Product Type

18.2.2. By End User

18.3. Canada Respiratory Devices Market Analysis

18.3.1. By Product Type

18.3.2. By End User

18.4. Brazil Respiratory Devices Market Analysis

18.4.1. By Product Type

18.4.2. By End User

18.5. U.K. Respiratory Devices Market Analysis

18.5.1. By Product Type

18.5.2. By End User

18.6. Germany Respiratory Devices Market Analysis

18.6.1. By Product Type

18.6.2. By End User

18.7. France Respiratory Devices Market Analysis

18.7.1. By Product Type

18.7.2. By End User

18.8. Italy Respiratory Devices Market Analysis

18.8.1. By Product Type

18.8.2. By End User

18.9. Spain Respiratory Devices Market Analysis

18.9.1. By Product Type

18.9.2. By End User

18.10. Russia Respiratory Devices Market Analysis

18.10.1. By Product Type

18.10.2. By End User

18.11. China Respiratory Devices Market Analysis

18.11.1. By Product Type

18.11.2. By End User

18.12. Japan Respiratory Devices Market Analysis

18.12.1. By Product Type

18.12.2. By End User

18.13. South Korea Respiratory Devices Market Analysis

18.13.1. By Product Type

18.13.2. By End User

18.14. India Respiratory Devices Market Analysis

18.14.1. By Product Type

18.14.2. By End User

18.15. Australia Respiratory Devices Market Analysis

18.15.1. By Product Type

18.15.2. By End User

18.16. South Africa Respiratory Devices Market Analysis

18.16.1. By Product Type

18.16.2. By End User

19. Market Structure Analysis

19.1. Market Analysis by Tier of Companies

19.2. Market Concentration

19.3. Market Share Analysis of Top Players

19.4. Market Presence Analysis

19.4.1. By Regional Footprint of Players

19.4.2. Product Footprint by Players

19.4.3. Channel Footprint by Players

20. Competition Analysis

20.1. Competition Dashboard

20.2. Competition Benchmarking

20.3. Competition Deep Dive (Tentative List)

20.3.1. Massimo Corporation

20.3.1.1. Overview

20.3.1.2. Product Portfolio

20.3.1.3. Key Financial

20.3.1.4. Sales Footprint

20.3.1.5. Analyst commentary

20.3.2. Teleflex Incorporated

20.3.2.1. Overview

20.3.2.2. Product Portfolio

20.3.2.3. Key Financial

20.3.2.4. Sales Footprint

20.3.2.5. Analyst commentary

20.3.3. Fisher & Paykel Healthcare Limited

20.3.3.1. Overview

20.3.3.2. Product Portfolio

20.3.3.3. Key Financial

20.3.3.4. Sales Footprint

20.3.3.5. Analyst commentary

20.3.4. ResMed Inc.

20.3.4.1. Overview

20.3.4.2. Product Portfolio

20.3.4.3. Key Financial

20.3.4.4. Sales Footprint

20.3.4.5. Analyst commentary

20.3.5. Hamilton Medical AG

20.3.5.1. Overview

20.3.5.2. Product Portfolio

20.3.5.3. Key Financial

20.3.5.4. Sales Footprint

20.3.5.5. Analyst commentary

20.3.6. Medtronic plc.

20.3.6.1. Overview

20.3.6.2. Product Portfolio

20.3.6.3. Key Financial

20.3.6.4. Sales Footprint

20.3.6.5. Analyst commentary

20.3.7. Koninklijke Philips N.V.

20.3.7.1. Overview

20.3.7.2. Product Portfolio

20.3.7.3. Key Financial

20.3.7.4. Sales Footprint

20.3.7.5. Analyst commentary

20.3.8. Smith’s Medical

20.3.8.1. Overview

20.3.8.2. Product Portfolio

20.3.8.3. Key Financial

20.3.8.4. Sales Footprint

20.3.8.5. Analyst commentary

20.3.9. General Electric Healthcare Limited

20.3.9.1. Overview

20.3.9.2. Product Portfolio

20.3.9.3. Key Financial

20.3.9.4. Sales Footprint

20.3.9.5. Analyst commentary

20.3.10. Drägerwerk AG & Co. KGaA

20.3.10.1. Overview

20.3.10.2. Product Portfolio

20.3.10.3. Key Financial

20.3.10.4. Sales Footprint

20.3.10.5. Analyst commentary

20.3.11. Inogen Inc.

20.3.11.1. Overview

20.3.11.2. Product Portfolio

20.3.11.3. Key Financial

20.3.11.4. Sales Footprint

20.3.11.5. Analyst commentary

21. Assumptions and Acronyms Used

22. Research Methodology

Major Companies

  • Massimo Corporation
  • Teleflex Incorporated
  • Fisher & Paykel Healthcare Limited
  • ResMed Inc.
  • Hamilton Medical AG
  • Medtronic plc.
  • Koninklijke Philips N.V.
  • Smiths Medical
  • General Electric Healthcare Limited
  • Drgerwerk AG & Co. KGaA
  • Inogen Inc.
  • Others

Segmentation

Product

  • Respiratory Consumables
    • Respiratory Mask
    • Nasal Cannulas
    • Oxygen Tubing Sets
    • Breathing Filters
  • Nebulizers
    • Compressed Jet Nebulizers
    • Ultrasonic Nebulizers
  • Oxygen Concentrators
    • Home Oxygen Concentrators
    • Portable Oxygen
    • Concentrators`
  • Positive Airway Pressure (PAP) Devices
  • Polysomnography Devices
    • Ambulatory PSG Devices
    • Clinical PSG Devices
  • Pulse Oximeters
  • Mechanical Ventilators
  • Spirometers

End Users

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Long Term Care Centers
  • Others

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF